TARGOCID
SANOFI
Identification
- Active ingredient (INN)
- TEICOPLANINE
- Internal code
- 13 X 340
- Country of Origin
- France
- Pharmaceutical form
- Lyophilisate + Solvent for IM/IV Use
- Prescription List
- Highly Regulated (List I)
- Packaging
- b/01fl. de pdre. + 01amp. de 3.2ml de solv. (eppi)
DAWA Clinical Workbench v2.0
Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.
Indications
The treatment is used in: skin infection, bone and joint infections, pneumonia, urinary tract infections, heart disease, dialysis (dial washing), serious bacterial infections such as MRSA, prevention of inflammation during operations.
Injecting solution can be used
Oral to treat intestinal infections.
Associated Conditions
There are currently insufficient studies to confirm the safe use of treatment on the foetus; treatment is used in case of greater risk to the foetus.
A doctor or pharmacist must be consulted before treatment is taken in case of pregnancy.
Breastfeeding: if it is released in the mother's milk, preferably a doctor's before use.
Mechanism of Action
Tycuplanin is an injection-based antibiotics, which belong to glympide, which is used to prevent the construction of the pettiduglycan necessary for building the bacteria cell wall.
Do you have questions about this? Ask Sina, artificial intelligence to answer all your medical questions, write your question here, Sina is preparing the answer for you.